Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
DTC Review Will Cost Industry $83,000 Per Ad Under FDA’s Final PDUFA Plan
Mar 26 2007
•
By
Brenda Sandburg
More from Archive
More from Pink Sheet